Hyperprogression and impact of tumor growth kinetics after PD1/PDL1 inhibition in head and neck squamous cell carcinoma

Background: Hyperprogressive disease (HPD) rate in head and neck squamous cell carcinoma (HNSCC) patients treated with immune checkpoint inhibitors (ICI) was determined using tumor growth kinetics (TGK) and compared with rapidly progressive screen-failure (SF) patients. The impact of TGK on outcomes...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncotarget
Main Authors: Karabajakian, Andy, Garrivier, Thibaut, Crozes, Carole, Gadot, Nicolas, Blay, Jean-Yves, Bérard, Frédéric, Céruse, Philippe, Zrounba, Philippe, Saintigny, Pierre, Mastier, Charles, Fayette, Jérôme
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2020
Teme:
Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7210015/
https://ncbi.nlm.nih.gov/pubmed/32405337
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27563
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki